Amedisys Inc (AMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Amedisys Inc (AMED) has a cash flow conversion efficiency ratio of 0.053x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($67.21 Million) by net assets ($1.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Amedisys Inc (AMED) strategic asset index to assess the company's strategic physical and investment asset allocation.
Amedisys Inc - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how Amedisys Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See what is Amedisys Inc's book value for net asset value and shareholders' equity analysis.
Amedisys Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amedisys Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hisense Kelon Electrical Holdings Co Ltd
SHE:000921
|
0.104x |
|
Avient Corp
NYSE:AVNT
|
-0.014x |
|
Cholamandalam Financial Holdings Limited
NSE:CHOLAHLDNG
|
-0.369x |
|
StubHub Holdings, Inc.
NYSE:STUB
|
0.002x |
|
ATS Corporation
NYSE:ATS
|
0.064x |
|
Quectel Wireless Solutions Co Ltd
SHG:603236
|
0.002x |
|
Wuxi Autowell Technology Co Ltd
SHG:688516
|
0.021x |
|
Trigano S.A.
PA:TRI
|
0.204x |
Annual Cash Flow Conversion Efficiency for Amedisys Inc (1994–2024)
The table below shows the annual cash flow conversion efficiency of Amedisys Inc from 1994 to 2024. For the full company profile with market capitalisation and key ratios, see AMED stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.18 Billion | $221.66 Million | 0.188x | +53.34% |
| 2023-12-31 | $1.12 Billion | $137.19 Million | 0.123x | +1.72% |
| 2022-12-31 | $1.11 Billion | $133.28 Million | 0.120x | -37.75% |
| 2021-12-31 | $976.32 Million | $188.89 Million | 0.193x | -45.72% |
| 2020-12-31 | $810.74 Million | $288.95 Million | 0.356x | +13.19% |
| 2019-12-31 | $641.51 Million | $202.00 Million | 0.315x | -32.00% |
| 2018-12-31 | $482.63 Million | $223.48 Million | 0.463x | +126.17% |
| 2017-12-31 | $516.43 Million | $105.73 Million | 0.205x | +51.64% |
| 2016-12-31 | $461.14 Million | $62.26 Million | 0.135x | -48.59% |
| 2015-12-31 | $410.44 Million | $107.78 Million | 0.263x | +259.39% |
| 2014-12-31 | $397.76 Million | $-65.53 Million | -0.165x | -160.01% |
| 2013-12-31 | $372.48 Million | $102.26 Million | 0.275x | +79.45% |
| 2012-12-31 | $454.23 Million | $69.49 Million | 0.153x | -43.83% |
| 2011-12-31 | $520.15 Million | $141.66 Million | 0.272x | +16.15% |
| 2010-12-31 | $879.72 Million | $206.27 Million | 0.234x | -30.29% |
| 2009-12-31 | $736.34 Million | $247.66 Million | 0.336x | +25.42% |
| 2008-12-31 | $562.12 Million | $150.74 Million | 0.268x | +29.01% |
| 2007-12-31 | $447.82 Million | $93.08 Million | 0.208x | +75.63% |
| 2006-12-31 | $364.01 Million | $43.08 Million | 0.118x | -47.65% |
| 2005-12-31 | $192.60 Million | $43.54 Million | 0.226x | +12.97% |
| 2004-12-31 | $148.47 Million | $29.71 Million | 0.200x | -52.79% |
| 2003-12-31 | $51.40 Million | $21.79 Million | 0.424x | -35.33% |
| 2002-12-31 | $16.96 Million | $11.12 Million | 0.655x | -71.14% |
| 2001-12-31 | $3.37 Million | $7.66 Million | 2.271x | +163.06% |
| 2000-12-31 | $-1.92 Million | $6.91 Million | -3.601x | -496.48% |
| 1999-12-31 | $-10.10 Million | $-9.18 Million | 0.908x | +237.93% |
| 1998-12-31 | $-11.58 Million | $7.63 Million | -0.658x | -377.44% |
| 1997-12-31 | $8.28 Million | $-1.14 Million | -0.138x | +33.56% |
| 1996-12-31 | $4.50 Million | $-934.84K | -0.208x | -155.79% |
| 1995-12-31 | $4.30 Million | $1.60 Million | 0.372x | +181.86% |
| 1994-12-31 | $2.20 Million | $-1.00 Million | -0.455x | -- |
About Amedisys Inc
Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services,… Read more